Latest Breaking News On - Chronic obstructive pulmonary disorder - Page 11 : comparemela.com

PAO Group, Inc.: PAOG Highlights ALKM $15 Million Production Facility In Conjunction With CBD Nutraceutical Plan Targeting $5 Billion Market

PAO Group, Inc.: PAOG Highlights ALKM $15 Million Production Facility In Conjunction With CBD Nutraceutical Plan Targeting $5 Billion Market ALKM - Alkame Confirms $15 Million Annual Revenue Bottling Production Potential PAOG recenlty released a preview of the company s plan to launch a CBD Nutraceuticals line of products. PAOG s CBD Nutraceuticals are expected to generate revenue this year, in 2021, while the company continues with its long-term CBD pharmaceutical developments. PAOG plans to develop and distribute its CBD nutraceuticals ALKM as a copacker, and North American Cannabis Holdings, Inc. (OTC Pink: USMJ) as a distributor. The 2020 CBD Nutraceuticals Market had an estimated value of $5.2 Billion and it is expected to reach $16.4 Billion by 2027.

PAOG Highlights ALKM $15 Million Production Facility In Conjunction With CBD Nutraceutical Plan Targeting $5 Billion Market

Held in Narada case, Sovan Chatterjee in house arrest after release from hospital

PAO Group, Inc.: PAOG Targets International Segment of $5 Billion CBD Nutraceutical Market

PAO Group, Inc.: PAOG Targets International Segment of $5 Billion CBD Nutraceutical Market Sandusky, Ohio (Newsfile Corp. - May 13, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today revealed it will include foreign sales in the planned Q4 launch of its three CBD Nutraceutical Products. The 2020 CBD Nutraceuticals Market had an estimated value of $5.2 Billion and it is expected to reach $16.4 Billion by 2027. That market value represents global sales. PAOG management is targeting specific international segments to be included in its Q4 sales launch. PAOG management anticipates a lower market entry expense in the targeted international segments. PAOG management also anticipates the international segments to likely contribute a major portion of its overall CBD Nutraceutical sales.

PAOG Introduces International Approach To Targeting $5 Billion CBD Nutraceutical Market

PAOG Introduces International Approach To Targeting $5 Billion CBD Nutraceutical Market News provided by Share this article Share this article SANDUSKY, Ohio, May 13, 2021 /PRNewswire/ PAO Group, Inc. (USOTC: PAOG) today revealed it will include foreign sales in the planned Q4 launch of its three CBD Nutraceutical Products. The 2020 CBD Nutraceuticals Market had an estimated value of $5.2 Billion and it is expected to reach $16.4 Billion by 2027. That market value represents global sales.  PAOG management is targeting specific international segments to be included in its Q4 sales launch.  PAOG management anticipates a lower market entry expense in the targeted international segments.  PAOG management also anticipates the international segments to likely contribute a major portion of its overall CBD Nutraceutical sales.